BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29222719)

  • 21. Slowing the degenerative process, long lasting effect of hyperbaric oxygen therapy in retinitis pigmentosa.
    Vingolo EM; Rocco M; Grenga P; Salvatore S; Pelaia P
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):93-8. PubMed ID: 17674017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual Field Progression in Retinitis Pigmentosa.
    Xu M; Zhai Y; MacDonald IM
    Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):56. PubMed ID: 32589198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.
    Birch DG; Bernstein PS; Iannacone A; Pennesi ME; Lam BL; Heckenlively J; Csaky K; Hartnett ME; Winthrop KL; Jayasundera T; Hughbanks-Wheaton DK; Warner J; Yang P; Fish GE; Teske MP; Sklaver NL; Erker L; Chegarnov E; Smith T; Wahle A; VanVeldhuisen PC; McCormack J; Lindblad R; Bramer S; Rose S; Zilliox P; Francis PJ; Weleber RG
    JAMA Ophthalmol; 2018 Aug; 136(8):849-856. PubMed ID: 29879277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRANSCORNEAL ELECTRICAL STIMULATION THERAPY MAY HAVE A STABILIZATION EFFECT ON MULTIFOCAL ELECTRORETINOGRAPHY FOR PATIENTS WITH RETINITIS PIGMENTOSA.
    Dizdar Yigit D; Sevik MO; Şahin Ö
    Retina; 2022 May; 42(5):923-933. PubMed ID: 34923514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid.
    Bhalla S; Joshi D; Bhullar S; Kasuga D; Park Y; Kay CN
    Br J Ophthalmol; 2013 Jul; 97(7):895-9. PubMed ID: 23603755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of residual retinal function by pupillary constrictions and phosphenes using transcorneal electrical stimulation in patients with retinal degeneration.
    Morimoto T; Fukui T; Matsushita K; Okawa Y; Shimojyo H; Kusaka S; Tano Y; Fujikado T
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1283-92. PubMed ID: 16550408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations.
    von Krusenstiern L; Liu J; Liao E; Gow JA; Chen G; Ong T; Lotery AJ; Jalil A; Lam BL; MacLaren RE;
    JAMA Ophthalmol; 2023 Mar; 141(3):275-283. PubMed ID: 36757689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transpalpebral electrical stimulation for the treatment of retinitis pigmentosa: study protocol for a series of N-of-1 single-blind, randomized controlled trial.
    Zhou W; Huang Z; Xu K; Li Y; Li X; Li J; Jin Y; Snellingen T; Liang L
    Trials; 2024 Jan; 25(1):89. PubMed ID: 38279157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of a vision-related activity scale for patients with retinitis pigmentosa.
    Costela FM; Pesudovs K; Sandberg MA; Weigel-DiFranco C; Woods RL
    Health Qual Life Outcomes; 2020 Jun; 18(1):196. PubMed ID: 32571342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcorneal electrical stimulation promotes the survival of photoreceptors and preserves retinal function in royal college of surgeons rats.
    Morimoto T; Fujikado T; Choi JS; Kanda H; Miyoshi T; Fukuda Y; Tano Y
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4725-32. PubMed ID: 17898297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 Gene.
    Chung DC; Bertelsen M; Lorenz B; Pennesi ME; Leroy BP; Hamel CP; Pierce E; Sallum J; Larsen M; Stieger K; Preising M; Weleber R; Yang P; Place E; Liu E; Schaefer G; DiStefano-Pappas J; Elci OU; McCague S; Wellman JA; High KA; Reape KZ
    Am J Ophthalmol; 2019 Mar; 199():58-70. PubMed ID: 30268864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the Electronic Retinal Implant Alpha AMS in Restoring Vision to Blind Patients with End-Stage Retinitis Pigmentosa.
    Edwards TL; Cottriall CL; Xue K; Simunovic MP; Ramsden JD; Zrenner E; MacLaren RE
    Ophthalmology; 2018 Mar; 125(3):432-443. PubMed ID: 29110946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An instrument capable of grading visual function: results from patients with retinitis pigmentosa.
    Tamai M; Kunikata H; Itabashi T; Kawamura M; Saigo Y; Sato H; Wada Y; Nakagawa Y
    Tohoku J Exp Med; 2004 Aug; 203(4):305-12. PubMed ID: 15297735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vision test variability in retinitis pigmentosa and psychosocial factors.
    Bittner AK; Ibrahim MA; Haythornthwaite JA; Diener-West M; Dagnelie G
    Optom Vis Sci; 2011 Dec; 88(12):1496-506. PubMed ID: 21946786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rates of change differ among measures of visual function in patients with retinitis pigmentosa.
    Holopigian K; Greenstein V; Seiple W; Carr RE
    Ophthalmology; 1996 Mar; 103(3):398-405. PubMed ID: 8600415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.
    Pierrache LH; Hartel BP; van Wijk E; Meester-Smoor MA; Cremers FP; de Baere E; de Zaeytijd J; van Schooneveld MJ; Cremers CW; Dagnelie G; Hoyng CB; Bergen AA; Leroy BP; Pennings RJ; van den Born LI; Klaver CC
    Ophthalmology; 2016 May; 123(5):1151-60. PubMed ID: 26927203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodal Imaging of Central Retinal Disease Progression in a 2-Year Mean Follow-up of Retinitis Pigmentosa.
    Sujirakul T; Lin MK; Duong J; Wei Y; Lopez-Pintado S; Tsang SH
    Am J Ophthalmol; 2015 Oct; 160(4):786-98.e4. PubMed ID: 26164827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Worse-than-usual visual fields measured in retinitis pigmentosa related to episodically decreased general health.
    Bittner AK; Haythornthwaite JA; Diener-West M; Dagnelie G
    Br J Ophthalmol; 2013 Feb; 97(2):145-8. PubMed ID: 23212205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sector retinitis pigmentosa.
    Van Woerkom C; Ferrucci S
    Optometry; 2005 May; 76(5):309-17. PubMed ID: 15884421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of the Visual Field Loss in Retinitis Pigmentosa Using Semi-Automated Kinetic Perimetry.
    Nowomiejska K; Brzozowska A; Koss MJ; Weleber RG; Schiefer U; Rejdak K; Juenemann AG; Maciejewski R; Rejdak R
    Curr Eye Res; 2016 Jul; 41(7):993-8. PubMed ID: 26470834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.